Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
批准号:
10782755
负责人:
SHALENDER BHASIN
金额:
$44.73万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2024-04-30
关键词:
Adverse eventAerobicAffectiveAndrogensCOVID-19 pandemicCardiovascular systemClinical ResearchClinical Trials Data Monitoring CommitteesConsultationsCost SavingsDiseaseDistressDouble-Blind MethodEligibility DeterminationEnrollmentEquilibriumEvaluationFatigueFunctional disorderFundingGleason Grade for Prostate CancerGoalsGuidelinesHematocrit procedureHuman ResourcesInstitutionInvestmentsLaboratoriesLiftingLipidsLocalized DiseaseMalignant neoplasm of prostateMedicalMonitorOrganParticipantPatient Self-ReportPersonal SatisfactionPhysical FunctionPlacebo ControlProceduresProfessional OrganizationsProstateProstate specific antigen measurementQuality of lifeRadical ProstatectomyRampRandomizedRecommendationRecording of previous eventsRecurrent diseaseRequest for ApplicationsResearchResearch ActivitySafetySavingsSex BehaviorSex FunctioningSexual DysfunctionSiteSouthwest Oncology GroupStructureSurveysSuspensionsSymptomsTestingTestosteroneUnited States National Institutes of HealthUrogenital CancerUrologyVO2maxclinical practicecoronavirus diseasedisorder riskefficacy evaluationefficacy trialhealth related quality of lifeimprovedinstrumentmenmuscle formmuscle strengthparent projectparticipant enrollmentpaymentperformance based measurementpre-pandemicprogramsprostate cancer survivorsrandomized trialrecruitscreeningsurvivorshipsymptomatic improvementtestosterone replacement therapy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
This application requests close-out funds to enable completion of the trial and
accomplishment of the proposed aims of the project. This planned extension of the trial,
discussed previously on several occasions during the past 2 years with the trial's DSMB
and the program staff, was necessitated because of the nationwide suspension of
clinical research activities in 2020 due to the onset of the COVID-19 pandemic. Even
after the complete suspension of non-Covid clinical research activities was lifted, the
subsequent ramp up of clinical research activities in 2020 and 2021 was substantially
slower than in the pre-pandemic period due to the COVID-related restrictions and other
reasons that are described in the Research Strategies section. These COVID-related
constraints substantially slowed participant enrollment and delayed the completion of
the trial. With the gradual lifting of these Covid-related restrictions during the past year,
and a number of steps implemented by the study team that are described in the
Research Strategies section, including the addition of a second trial site at the Brady
Urology Center at the Johns Hopkin Medical Institutions; increased personnel effort for
participant screening; and some DSMB-recommended revisions of eligibility criteria, the
enrollment in the trial has increased substantially averaging 6 randomizations each
month during the past several months. As described in the Research Strategies section,
61 participants had been enrolled as of December 31, 2022, including 23 in the past 4
months. We anticipate enrolling 85 subjects by the end of the current funding period
(April 30, 2023) and completing the enrollment during the extension period. The close-
out funds are requested for completing the planned recruitment in the trial and
accomplishing the approved aims of this project. There was saving of costs associated
with laboratory tests, procedures, and subject payments; these savings will be carried
forward and no additional funds have been requested for these activities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
-
批准号:10430705
-
项目类别:
-
资助金额:$89.97万
-
财政年份:2022
-
负责人:SHALENDER BHASIN
-
依托单位:
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
-
批准号:10668324
-
项目类别:
-
资助金额:$86.81万
-
财政年份:2022
-
负责人:SHALENDER BHASIN
-
依托单位:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
-
批准号:10311161
-
项目类别:
-
资助金额:$75.21万
-
财政年份:2021
-
负责人:SHALENDER BHASIN
-
依托单位:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
-
批准号:10457489
-
项目类别:
-
资助金额:$87.31万
-
财政年份:2021
-
负责人:SHALENDER BHASIN
-
依托单位:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
-
批准号:10634622
-
项目类别:
-
资助金额:$88.16万
-
财政年份:2021
-
负责人:SHALENDER BHASIN
-
依托单位:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
-
批准号:10398005
-
项目类别:
-
资助金额:$72.19万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
-
批准号:9767249
-
项目类别:
-
资助金额:$74.0万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
-
批准号:10159744
-
项目类别:
-
资助金额:$103.03万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
-
批准号:10398790
-
项目类别:
-
资助金额:$99.83万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
-
批准号:9918241
-
项目类别:
-
资助金额:$75.47万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
-
批准号:10764596
-
项目类别:
-
资助金额:$44.64万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
-
批准号:9750591
-
项目类别:
-
资助金额:$75.47万
-
财政年份:2018
-
负责人:SHALENDER BHASIN
-
依托单位:
Anti-Geronic Factors, GDF11 and Oxytocin, and Aging-Related Phenotypes
-
批准号:9341419
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2016
-
负责人:SHALENDER BHASIN
-
依托单位:
A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
-
批准号:9276519
-
项目类别:
-
资助金额:$68.7万
-
财政年份:2015
-
负责人:SHALENDER BHASIN
-
依托单位:
A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
-
批准号:8693498
-
项目类别:
-
资助金额:$73.96万
-
财政年份:2015
-
负责人:SHALENDER BHASIN
-
依托单位:
Muscle Mass and Strength Cutpoints in Persons at Risk of Mobility Disability
-
批准号:9145622
-
项目类别:
-
资助金额:$75.07万
-
财政年份:2015
-
负责人:SHALENDER BHASIN
-
依托单位:
Muscle Mass and Strength Cutpoints in Persons at Risk of Mobility Disability-A1
-
批准号:9472426
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2015
-
负责人:SHALENDER BHASIN
-
依托单位:
A Novel System to Detect Falls in Real-life Conditions
-
批准号:9144707
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2015
-
负责人:SHALENDER BHASIN
-
依托单位:
Randomized Trial of a Multifactorial Fall Injury Prevention Strategy
-
批准号:8768759
-
项目类别:
-
资助金额:$764.55万
-
财政年份:2014
-
负责人:SHALENDER BHASIN
-
依托单位:
Randomized Trial of a Multifactorial Fall Injury Prevention Strategy
-
批准号:8856458
-
项目类别:
-
资助金额:$616.73万
-
财政年份:2014
-
负责人:SHALENDER BHASIN
-
依托单位:
海外基金